The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Activity is determined by the ability to chemoattract total Human lymphocytes and Murine T-cells at a concentration between 1-10 ng/ml.
% SDS-PAGE. Purity by SDS-PAGE and HPPLC is greater than 97%.
Concentration information loading...
Shipped at 4°C. Store at -20ºC.
This product is an active protein and may elicit a biological response in vivo, handle with caution.
It is recommended to reconstitute the lyophilized product with sterile water at a concentration of 0.1 mg/ml, which can be further diluted into other aqueous solutions.
Beta chemokine RANTES
Beta chemokine RANTES precursor
C C motif chemokine 5
Chemokine (C C motif) ligand 5
Chemokine CC Motif Ligand 5
Eosinophil chemotactic cytokine
Regulated upon activation normally T expressed and presumably secreted
Small inducible cytokine A5
Small inducible cytokine A5 (RANTES)
Small inducible cytokine subfamily A (Cys Cys) member 5
Small-inducible cytokine A5
T cell specific protein p288
T cell specific RANTES protein
T cell-specific protein P228
T-cell-specific protein RANTES
Chemoattractant for blood monocytes, memory T-helper cells and eosinophils. Causes the release of histamine from basophils and activates eosinophils. Binds to CCR1, CCR3, CCR4 and CCR5. One of the major HIV-suppressive factors produced by CD8+ T-cells. Recombinant RANTES protein induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form RANTES(3-68) acts as a natural chemotaxis inhibitor and is a more potent inhibitor of HIV-1-infection. The second processed form RANTES(4-68) exhibits reduced chemotactic and HIV-suppressive activity compared with RANTES(1-68) and RANTES(3-68) and is generated by an unidentified enzyme associated with monocytes and neutrophils.
T-cell and macrophage specific.
Belongs to the intercrine beta (chemokine CC) family.
N-terminal processed form RANTES(3-68) is produced by proteolytic cleavage, probably by DPP4, after secretion from peripheral blood leukocytes and cultured sarcoma cells. The identity of the O-linked saccharides at Ser-27 and Ser-28 are not reported in PubMed:1380064. They are assigned by similarity.